Clinical trial
Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or…
NCT00263614 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00263614 |
|---|---|
| Title | Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases. |
| Official title | A Cross Sectional and Retrospective Evaluation in HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B (CHB)Patients With Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases(The MELT Study). |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Chronic Hepatitis B |
| Enrollment | 100 |
| Start date | Dec 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Dec 9, 2005 |
| Last update posted | Feb 3, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: